(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.48%) $79.33
(-0.39%) $2.03
(0.21%) $2 314.50
(0.51%) $26.97
(0.38%) $966.30
(-0.05%) $0.932
(-0.15%) $10.98
(-0.09%) $0.797
(-0.01%) $91.12
Live Chart Being Loaded With Signals
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services...
Stats | |
---|---|
Today's Volume | 18 727.00 |
Average Volume | 51 504.00 |
Market Cap | 77.12M |
EPS | $0 ( 2024-03-26 ) |
Next earnings date | ( $0 ) 2024-06-04 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.860 |
ATR14 | $0.0180 (2.37%) |
Volume Correlation
Burning Rock Biotech Ltd Correlation
10 Most Positive Correlations | |
---|---|
BLTE | 0.92 |
SOPA | 0.918 |
PHCF | 0.917 |
ONCR | 0.911 |
IART | 0.903 |
MLAB | 0.901 |
HIBB | 0.893 |
VLCN | 0.889 |
JRJC | 0.887 |
CBLI | 0.885 |
10 Most Negative Correlations | |
---|---|
AVGO | -0.935 |
SMCI | -0.934 |
NVDA | -0.933 |
BWC | -0.922 |
HGBL | -0.917 |
BSY | -0.914 |
ELTK | -0.914 |
ACLS | -0.911 |
BOTZ | -0.911 |
AIB | -0.911 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Burning Rock Biotech Ltd Correlation - Currency/Commodity
Burning Rock Biotech Ltd Financials
Annual | 2023 |
Revenue: | $537.44M |
Gross Profit: | $363.23M (67.59 %) |
EPS: | $-6.38 |
FY | 2023 |
Revenue: | $537.44M |
Gross Profit: | $363.23M (67.59 %) |
EPS: | $-6.38 |
FY | 2022 |
Revenue: | $563.24M |
Gross Profit: | $380.04M (67.47 %) |
EPS: | $-9.35 |
FY | 2021 |
Revenue: | $507.86M |
Gross Profit: | $364.15M (71.70 %) |
EPS: | $-7.65 |
Financial Reports:
No articles found.
Burning Rock Biotech Ltd
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and OncoScreen ParpMatch and OncoCompass ParpMatch to target critical genes associated with homologous recombination deficiency. In addition, the company has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China. It has collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. The company was incorporated in 2014 and is headquartered in Guangzhou, China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators